CClinicalTrials.gg
CompletedNCT04548141SAPHIRUpdated Jun 24, 2022

Quick Questionnaire to Evaluate Physical Activity

An interventional study of Questionnaire in Sedentary Behavior, sponsored by University Hospital, Angers. Completed at 1 site in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-06-24.

Sponsored by University Hospital, Angers · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to test and validate a new questionnaire (SAPHIR) in order to get an evaluation of patients physical activity.

Read the detailed description

Two questionnaires the SAPHIR and the "International Physical Activity Questionnaire" (IPAQ) are submitted (self completion) to patients referred for consultation.

Retrival of physical activity data on podometer if available

02

Conditions studied

  • Sedentary Behavior

Keywords

  • Physical activity
  • Questionnaire
03

In context

Lead sponsor

University Hospital, Angers is the lead sponsor of 464 studies on the registry; 116 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • French Native language
  • Covered by the French social care system
  • Be referred for a consultation to the Sports Medicine Service of Angers Hospital or to the CRSS of Angers

Exclusion criteria

Exclusion Criteria:

  • Person opposed to participating in the research
  • Person unable to understand the objectives of the study
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
140 participants (actual)

Study arms

  • Experimental
    Active adults

    Adults coming for a visit for sports activity participation and submitted the SAPHIR questionnaire

    Other: Questionnaire

Interventions

  • OtherQuestionnaire

    Scoring of the IPAQ is performed according to references. Scoring of the SAPHIR has been submitted for copyright protection (involves a series of 23 additions)

06

What researchers measure

Primary outcomes

  1. Proportion of questionnaires with errors after self completion

    Estimation of the percentage of errors with 90% confidence interval Comparison of the two percentages

    Time frame: 1 day

Secondary outcomes

  1. Facility of the filling of the questionnaires

    Ease of use évaluation for the patient using Likert scale (from "Totally agree" to "not agree at all" in 5 grades)

    Time frame: 1 day

  2. Correlation of the SAPHIR questionnaire to the IPAQ questionnaire

    Correlation coefficient with the IPAQ questionnaire

    Time frame: 1 day

  3. Correlation of the SAPHIR questionnaire to the number of weekly steps for patients who have a pedometer available

    The correlation coefficient with the number of steps will be studied

    Time frame: 1 day

07

Study locations

1 site
  • Centre hospitalier universitaire
    Angers, 49933, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 24, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04548141
Lead sponsor
University Hospital, Angers
Responsible party
DENISE JOLIVOT (Doctor, University Hospital, Angers) — Principal investigator
First posted
Sep 14, 2020
Start date
Nov 26, 2020
Primary completion
Sep 21, 2021
Completion
Sep 21, 2021
Last update
Jun 24, 2022

Study contacts

Pierre ABRAHAM
principal investigator · University and Hospital in Angers

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion